SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-22-092371
Filing Date
2022-04-01
Accepted
2022-03-31 21:08:24
Documents
52
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d332382d10k.htm   iXBRL 10-K 1267045
2 EX-4.2 d332382dex42.htm EX-4.2 85404
3 EX-31.1 d332382dex311.htm EX-31.1 10404
4 EX-31.2 d332382dex312.htm EX-31.2 10551
5 EX-32.1 d332382dex321.htm EX-32.1 4437
6 EX-32.2 d332382dex322.htm EX-32.2 4445
  Complete submission text file 0001193125-22-092371.txt   4365339

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kvsa-20211231.xsd EX-101.SCH 35348
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kvsa-20211231_cal.xml EX-101.CAL 26357
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kvsa-20211231_def.xml EX-101.DEF 192812
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kvsa-20211231_lab.xml EX-101.LAB 252140
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kvsa-20211231_pre.xml EX-101.PRE 246499
46 EXTRACTED XBRL INSTANCE DOCUMENT d332382d10k_htm.xml XML 388200
Mailing Address 2128 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2128 SAND HILL ROAD MENLO PARK CA 94025 650-376-8500
Khosla Ventures Acquisition Co. (Filer) CIK: 0001841873 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40131 | Film No.: 22795413
SIC: 2834 Pharmaceutical Preparations